Abstract
Aim:
The potential for topical delivery of meloxicam was investigated by examining its pharmacokinetic profiles in plasma and synovial fluid following oral and transdermal administration in Beagle dogs.
Methods:
The experiment was a two-period, crossover design using 6 Beagle dogs. Meloxicam tablets were administered orally at a dose of 0.31 mg/kg, and meloxicam gel was administered transdermally at a dose of 1.25 mg/kg. Drug concentrations in plasma and synovial fluid were determined by liquid chromatography-tandem mass spectrometry (LC/MS/MS). The pharmacokinetic parameters were calculated using the Topfit 2.0 program.
Results:
The pharmacokinetic results showed that AUC0–t (23.9±8.26 μg.h.mL−1) in plasma after oral administration was significantly higher than after transdermal delivery (1.00±0.43 μg.h.mL−1). In contrast, the ratio of the average concentration in synovial fluid to that in plasma following transdermal administration was higher than that for an oral delivery. The synovial fluid concentration in the treated leg was much higher than that in the untreated leg, whereas the synovial fluid concentration in the untreated leg was similar to the plasma concentration.
Conclusion:
The high concentration ratio of synovial fluid to plasma indicates direct penetration of meloxicam following topical administration to the target tissue. This finding is further supported by the differences observed in meloxicam concentrations in synovial fluid in the treated and untreated joints at the same time point. Our results suggest that transdermal delivery of meloxicam is a promising method for decreasing its adverse systemic effects.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Davies NM, Skjodt NM . Clinical pharmacokinetics of meloxicam. Clin Pharmacokinet 1999; 36: 115–26.
Singh G, Lanes S, Triadafilopoulos G . Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. Am J Med 2004; 117: 100–17.
Noble S, Balfour JA . Meloxicam. Drugs 1996; 51: 424–30.
Gupta SK, Bansal P, Bhardwaj RK, Jaiswal J, Velpandian T . Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application. Skin Pharmacol Appl Skin Physiol 2002; 15: 105–11.
Bevis PJ, Bird HA, Lapham G . An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment. Br J Rheumatol 1996; 35: 56–60.
Lee CM, Maibach HI . Deep percutaneous penetration into muscles and joints. J Pharm Sci 2006; 95: 1405–13.
Heyneman CA, Lawless-Liday C, Wall GC . Oral versus topical NSAIDs in rheumatic diseases. Drugs 2000; 60: 555–74.
Singh P, Roberts MS . Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther 1994; 268: 144–51.
Li YJ, Pan Y, Xu H, Wei G, Zheng JM . Pharmacokinetics and local tissue disposition of piroxicam following topical and oral application in rats. J Chin Pharm Sci 2002; 11: 85–90.
Suh H, Jun HW, Dzimianski MT, Lu GW . Pharmacokinetic and local tissue disposition studies of naproxen following topical and systemic administration in dogs and rats. Biopharm Drug Dispos 1997; 18: 623–33.
Yuan Y, Chen XY, Zhong DF . Determination of meloxicam in human plasma by liquid chromatography-tandem mass spectrometry following transdermal administration. J Chromatogr B 2007; 852: 650–4.
Toutain PL, Cester CC . Pharmacokinetic-pharmacodynamic relationships and dose response to meloxicam in horses with induced arthritis in the right carpal joint. Am J Vet Res 2004; 65: 1533–41.
McNeill SC, Pot ts RO, Francoeur ML . Local enhanced topical delivery (LETD) of drugs: Does it truly exist? Pharm Res 1992; 9: 1422–7.
Hui X, Anigbogu A, Singh P, Xiong G, Poblete N, Liu P, Maibach HI . Pharmacokinetic and local tissue disposition of [14C]sodium diclofenac following iontophoresis and systemic administration in rabbits. J Pharm Sci 2001; 90: 1269–76.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuan, Y., Chen, Xy., Li, Sm. et al. Pharmacokinetic studies of meloxicam following oral and transdermal administration in Beagle dogs. Acta Pharmacol Sin 30, 1060–1064 (2009). https://doi.org/10.1038/aps.2009.73
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2009.73
